HK1009936A1 - Polymer coated tablet comprising amoxycillin and clavulanate - Google Patents

Polymer coated tablet comprising amoxycillin and clavulanate

Info

Publication number
HK1009936A1
HK1009936A1 HK98110787A HK98110787A HK1009936A1 HK 1009936 A1 HK1009936 A1 HK 1009936A1 HK 98110787 A HK98110787 A HK 98110787A HK 98110787 A HK98110787 A HK 98110787A HK 1009936 A1 HK1009936 A1 HK 1009936A1
Authority
HK
Hong Kong
Prior art keywords
amoxycillin
clavulanate
coated tablet
polymer coated
polymer
Prior art date
Application number
HK98110787A
Other languages
English (en)
Inventor
C P Conley
N P Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1009936(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1009936A1 publication Critical patent/HK1009936A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK98110787A 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavulanate HK1009936A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations
PCT/EP1995/001463 WO1995028927A1 (en) 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate

Publications (1)

Publication Number Publication Date
HK1009936A1 true HK1009936A1 (en) 1999-06-11

Family

ID=10754044

Family Applications (5)

Application Number Title Priority Date Filing Date
HK99105804A HK1021860A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
HK01107178A HK1036404A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK03101681.9A HK1050992A1 (zh) 1994-04-23 1998-09-21 含有藥物配方的阿莫西林和克拉維酸
HK98110787A HK1009936A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavulanate
HK00104976A HK1027024A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavunalate

Family Applications Before (3)

Application Number Title Priority Date Filing Date
HK99105804A HK1021860A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
HK01107178A HK1036404A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK03101681.9A HK1050992A1 (zh) 1994-04-23 1998-09-21 含有藥物配方的阿莫西林和克拉維酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK00104976A HK1027024A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavunalate

Country Status (35)

Country Link
US (1) US6051255A (da)
EP (5) EP0758235B1 (da)
JP (1) JP3622975B2 (da)
CN (1) CN1134258C (da)
AP (2) AP564A (da)
AT (6) ATE203161T1 (da)
AU (1) AU684949B2 (da)
BG (1) BG62842B1 (da)
BR (1) BR9507502A (da)
CA (1) CA2188496A1 (da)
CZ (2) CZ294168B6 (da)
DE (5) DE29522153U1 (da)
DK (4) DK1093813T3 (da)
DZ (1) DZ1876A1 (da)
ES (4) ES2180251T3 (da)
FI (1) FI964249A0 (da)
GB (1) GB9408117D0 (da)
GR (2) GR3035031T3 (da)
HK (5) HK1021860A1 (da)
HU (1) HU228399B1 (da)
IL (1) IL113433A (da)
MA (1) MA23528A1 (da)
MY (1) MY115351A (da)
NO (1) NO310703B1 (da)
NZ (1) NZ285080A (da)
OA (1) OA10377A (da)
PL (1) PL316966A1 (da)
PT (4) PT978276E (da)
RO (1) RO116997B1 (da)
RU (1) RU2152213C1 (da)
SA (1) SA95160343B1 (da)
SI (1) SI0758235T1 (da)
SK (1) SK282594B6 (da)
WO (1) WO1995028927A1 (da)
ZA (1) ZA953236B (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
JP3501289B2 (ja) * 1995-09-07 2004-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
WO1998034598A2 (en) * 1997-02-07 1998-08-13 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
ES2201468T3 (es) * 1997-02-14 2004-03-16 Laboratoire Glaxosmithkline S.A.S. Preparacion farmaceutica que comprende amoxicilina y clavulanato.
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
WO1999011261A1 (en) * 1997-08-29 1999-03-11 Dsm N.V. Granules free of excipients
AU747099B2 (en) 1997-10-31 2002-05-09 Pharmacia Corporation Gellan gum tablet coating
ATE260096T1 (de) 1999-04-01 2004-03-15 Dsm Ip Assets Bv Agglomerate durch kristallisation
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
ITMI20000788A1 (it) * 1999-04-13 2001-10-11 Beecham Pharmaceuticals Pte Li Nuovo metodo di trattamento
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) * 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003066053A1 (en) * 2002-02-07 2003-08-14 Rutgers, The State University Antibiotic polymers
NZ534333A (en) * 2002-02-14 2006-05-26 Glaxo Group Ltd Pharmaceutical composition comprising N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide or salt, and process for preparing thereof comprising dry granulation
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2535177A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
DE10341264A1 (de) 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
WO2005085245A1 (en) 2004-03-08 2005-09-15 Prosidion Limited Pyrrolopyridine-2-carboxylic acid hydrazides
CA2572292A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
CN101171006B (zh) 2005-05-20 2010-12-01 第一三共株式会社 薄膜包衣制剂
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
PE20121478A1 (es) * 2009-09-18 2012-11-12 Sanofi Sa Formulaciones en comprimido de teriflunomida: "(4'-trifluorometilfenil) amida del acido (z)-2-ciano-3-hidroxibut-2-enoico con estabilidad mejorada
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI20000788A1 (it) * 1999-04-13 2001-10-11 Beecham Pharmaceuticals Pte Li Nuovo metodo di trattamento
AU2001292185A1 (en) * 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
NO310703B1 (no) 2001-08-20
GR3035031T3 (en) 2001-03-30
PT978276E (pt) 2003-01-31
PT758235E (pt) 2001-10-31
GR3036844T3 (en) 2002-01-31
FI964249A (fi) 1996-10-22
PL316966A1 (en) 1997-03-03
IL113433A (en) 2003-06-24
ZA953236B (en) 1995-12-27
MY115351A (en) 2003-05-31
HU9602922D0 (en) 1996-12-30
JPH09512027A (ja) 1997-12-02
EP1093813A2 (en) 2001-04-25
PT1093813E (pt) 2003-02-28
DK1093813T3 (da) 2003-02-17
EP1243267A3 (en) 2002-10-30
AT5349U1 (de) 2002-06-25
SK135496A3 (en) 1997-05-07
CZ11376U1 (cs) 2001-07-12
ATE226074T1 (de) 2002-11-15
CN1149829A (zh) 1997-05-14
SI0758235T1 (en) 2001-10-31
ATE203161T1 (de) 2001-08-15
BG100933A (en) 1997-07-31
DK0978276T3 (da) 2003-01-20
SK282594B6 (sk) 2002-10-08
US6051255A (en) 2000-04-18
MA23528A1 (fr) 1995-12-31
DE69528204T2 (de) 2003-08-07
HK1036404A1 (en) 2002-01-04
DE69528608D1 (de) 2002-11-21
BR9507502A (pt) 1997-09-02
AP564A (en) 1996-11-21
ES2161288T3 (es) 2001-12-01
HK1027024A1 (en) 2001-01-05
EP1093813B1 (en) 2002-10-16
DE69528608T2 (de) 2003-06-26
RU2152213C1 (ru) 2000-07-10
EP0761218B1 (en) 2000-10-11
ES2152485T3 (es) 2001-02-01
DE69521799T2 (de) 2002-06-13
GB9408117D0 (en) 1994-06-15
FI964249A0 (fi) 1996-10-22
NO964488L (no) 1996-12-17
EP0758235B1 (en) 2001-07-18
AP9600868A0 (en) 1996-10-31
PT761218E (pt) 2001-03-30
EP1093813A3 (en) 2001-05-30
DE29522153U1 (de) 2000-04-06
JP3622975B2 (ja) 2005-02-23
DE69521799D1 (de) 2001-08-23
NZ285080A (en) 1998-05-27
CA2188496A1 (en) 1995-11-02
CZ309096A3 (en) 1997-04-16
DE69528204D1 (de) 2002-10-17
HK1050992A1 (zh) 2003-07-18
AP9500733A0 (en) 1995-04-30
RO116997B1 (ro) 2001-09-28
AU2406895A (en) 1995-11-16
HUT76335A (en) 1997-08-28
HU228399B1 (en) 2013-03-28
SA95160343B1 (ar) 2005-05-04
CZ294168B6 (cs) 2004-10-13
DE69519093D1 (de) 2000-11-16
EP0978276A2 (en) 2000-02-09
EP0758235A1 (en) 1997-02-19
NO964488D0 (no) 1996-10-22
WO1995028927A1 (en) 1995-11-02
OA10377A (en) 2001-11-21
EP1243267A2 (en) 2002-09-25
DZ1876A1 (fr) 2002-02-17
IL113433A0 (en) 1995-07-31
HK1021860A1 (en) 2000-07-07
DK0758235T3 (da) 2001-10-29
EP0978276B1 (en) 2002-09-11
AT5350U1 (de) 2002-06-25
ATE196845T1 (de) 2000-10-15
ES2182754T3 (es) 2003-03-16
EP0978276A3 (en) 2000-04-12
DK0761218T3 (da) 2000-12-18
EP0761218A1 (en) 1997-03-12
CN1134258C (zh) 2004-01-14
ATE223706T1 (de) 2002-09-15
DE69519093T2 (de) 2001-07-19
ES2180251T3 (es) 2003-02-01
BG62842B1 (bg) 2000-09-29
AU684949B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
HK1009936A1 (en) Polymer coated tablet comprising amoxycillin and clavulanate
GB2298422B (en) Compounds and their use
ZA966494B (en) New drugs and their use
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
HUP9901092A3 (en) Benzimidazole compounds and their pharmaceutical use
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU4009795A (en) Heterocyclic compounds and their use
GR3036722T3 (en) Composition comprising amoxycillin and clavulanic acid
AU1081897A (en) Heterocyclic compounds and their use
AU3634595A (en) Bis-oxazolidines and their use
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
GB9514816D0 (en) Substances and their medical use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
HUP9602872A3 (en) Penem derivatives and antimicrobial agent containing the same
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU6366096A (en) Solid polymeric products and their use
AU1292995A (en) Bis-oxazolidine compounds and their use
AU7078094A (en) Allatostatins and their use
AU1141497A (en) Heterocyclic compounds and their use
AU5405296A (en) Iso-alpha-acid formulation and its use
AU6470996A (en) 4a-aryldecahydroisoquinoline compounds and medicinal uses thereof
AU5930996A (en) Contrast medium and its use
AU4677196A (en) Phenylamidinothiophene derivatives and antiphlogistic agent containing the same

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150418